"FDA Probes Semaglutide Drugs for Side Effects Amid Weight Loss Claims"
TL;DR Summary
The FDA is investigating reports of severe side effects from GLP-1 agonist drugs like Ozempic, Wegovy, and Zepbound, which are used for weight loss and type 2 diabetes treatment. Side effects include alopecia, aspiration, and suicidal ideation. Despite the investigation, the FDA does not advise discontinuing the drugs without consulting a doctor. These drugs, which work by suppressing appetite, are also being explored for potential benefits in preventing heart disease, Alzheimer's, and aiding in substance abuse treatment. Pharma companies like Novo Nordisk and Eli Lilly are facing lawsuits over other side effects such as "stomach paralysis."
- FDA Investigates Ozempic, Wegovy After Reports of Alarming Side Effects The Messenger
- Popular diabetes, weight loss drugs not linked to increase in suicidal thoughts: Research The Hill
- Weight loss drug warning FOX 26 Houston
- FDA Investigating Link Between Semaglutide and Hair Loss, Suicidal Thoughts Futurism
- FDA probes side effects of weight-loss drugs The Hill
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
1 min
vs 2 min read
Condensed
73%
358 → 96 words
Want the full story? Read the original article
Read on The Messenger